Early cerebral hypoxia in extremely preterm infants and neurodevelopmental impairment at 2 year of age: A post hoc analysis of the SafeBoosC II trial

Early cerebral hypoxia in extremely preterm infants and neurodevelopmental impairment at 2 year of age: A post hoc analysis of the SafeBoosC II trial

<h4>Background</h4> The SafeBoosC II, randomised clinical trial, showed that the burden of cerebral hypoxia was reduced with the combination of near infrared spectroscopy and a treatment guideline in extremely preterm infants during the first 72 hours after birth. We have previously repo...

Full description

Bibliographic Details
Main Authors: Anne Mette Plomgaard, Christoph E. Schwarz, Olivier Claris, Eugene M. Dempsey, Monica Fumagalli, Simon Hyttel-Sorensen, Petra Lemmers, Adelina Pellicer, Gerhard Pichler, Gorm Greisen
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786171/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786171/?tool=EBI

Similar Items